Welcome to our dedicated page for Psyched Wellness news (Ticker: PSYCF), a resource for investors and traders seeking the latest updates and insights on Psyched Wellness stock.
Psyched Wellness Ltd. (PSYCF) provides innovative mushroom-derived wellness products through its proprietary Amanita Muscaria extraction technology. This news hub offers investors and industry observers centralized access to official corporate developments and market-related updates.
Track financial disclosures, product launches, and strategic partnerships alongside regulatory milestones in the evolving nutraceutical sector. Our curated feed includes earnings reports, retail distribution expansions, and scientific research advancements related to PSYCF's functional mushroom supplements.
Key updates cover formulation innovations like water-based extracts and gummy products, supply chain developments, and D2C platform enhancements. Users gain insights into the company's operational strategies while monitoring its position in the competitive wellness supplements market.
Bookmark this page for streamlined access to verified PSYCF news, enabling informed analysis of the company's progress in bringing Amanita Muscaria-based solutions to global consumers.
Psyched Wellness (CSE: PSYC) (OTCQB: PSYCF) has completed an initial pilot run of a new 4 oz dietary supplement shot through its US subsidiary, AME Wellness Inc., in collaboration with Zerkalo
The pilot program aims to beta test the shot with select consumers to gather feedback on taste, effects, and marketing data. The company will also evaluate its website, third-party logistics, and shipping processes to ensure proper fulfillment capabilities before the product launch.
CEO Jeff Stevens expressed excitement about this development phase of the new dietary supplement shot, praising Zerkalo's brand development efforts. The company plans to expand its route-to-market partnerships nationwide for their product line.
Psyched Wellness (CSE: PSYC) (OTCQB: PSYCF), a life sciences company focused on Amanita Muscaria mushroom products, has announced key developments in their operations. The company will conduct a Genotoxicity Study on their proprietary Amanita Muscaria Extract (AME-1), following a comprehensive review of scientific data.
The company has successfully completed a production run for AME-1 and Calm products, ensuring sufficient inventory for online and retail orders. They are actively working to secure a long-term manufacturing agreement to meet growing demand.
Additionally, their consultant Zerkalo is making progress in developing new dietary supplement products using AME-1. The company has scheduled its Annual General and Special Meeting for May 15, 2025, and is expanding their route-to-market partnerships nationwide.
Psyched Wellness (CSE: PSYC) (OTCQB: PSYCF) announces changes to its board of directors. Harrison Aaron, a nominee of Gotham Green Partners, has resigned effective November 22, 2024. Trevor Mayer, Associate General Counsel at Gotham Green, has been appointed as the replacement nominee director. Mayer, who joined Gotham Green in 2019, brings experience in private equity M&A and fund formation from his previous roles at Kirkland & Ellis LLP and Cooley LLP. He graduated with honors from the University of Chicago Law School and the University of Texas at Austin.
Psyched Wellness (CSE: PSYC) (OTCQB: PSYCF) has announced a supply chain disruption at its sole US manufacturing facility on July 27, 2024. The facility, operated by a third-party contractor, produces Psyched's proprietary extracts AME-1 and Calm. In response, the company has suspended online sales to prioritize supporting retail partners and monthly subscribers for the next 8-12 weeks using existing inventory.
CEO Jeffrey Stevens stated that the company is focused on securing additional co-manufacturers to resume production as soon as possible. This disruption highlights the importance of a reliable supply chain for Psyched Wellness's operations and its commitment to maintaining product availability for customers.
Psyched Wellness (CSE: PSYC) (OTCQB: PSYCF), a company focused on Amanita Muscaria mushroom products, has expanded its retail partnerships to include Harmons, a Utah-based upscale supermarket chain. Calm, their product, will be available in 16 Harmons locations. To support this, Psyched has engaged UNFI, the largest health and specialty food distributor in North America.
The company has also appointed Kyle Nazareth as Chief Financial Officer, effective July 17, 2024. Nazareth brings over a decade of experience in managing public companies and advising on capital market transactions. He succeeds Keith Li, who served as CFO since January 2020.
Psyched Wellness continues to focus on partnering with specialty retailers offering high-quality products, aiming to differentiate itself as the first legal Amanita Muscaria-derived product for human consumption in the United States.
Psyched Wellness, a life sciences company focused on Amanita Muscaria mushroom-derived products, is set to launch Amanita Muscaria watermelon gummies in the U.S. this summer. These gummies, named "Fly (Agaric)", will be the first legal and safe gummies of their kind in the U.S., utilizing the company's proprietary extract, AME-1. The product responds to customer preference for gummies, offering convenience and flavor. Psyched Wellness plans to expand its market reach and anticipates these gummies will outperform their tincture sales. For more information, visit psyched-wellness.com or contact their sales team at sales@psyched-wellness.com.
Psyched Wellness announced the grant of 3,800,000 stock options to its directors, officers, consultants, and employees under its Stock Option Plan. These options will vest in four months and the underlying shares are subject to a four-month hold period as per CSE policies. CEO Jeff Stevens expressed the company's commitment to reward its team for securing a $7.5M USD investment from Gotham Green Partners, ensuring alignment with the company's success. The company aims to boost direct-to-consumer (D2C) sales through its online store and expand its presence in brick-and-mortar retailers. Psyched Wellness is the first to offer Amanita Muscaria products in Erewhon, Market of Choice, and Good Earth Markets. Their proprietary extract, AME-1, is the first legal Amanita Muscaria extract for human consumption in the USA, positioning the company for upcoming retail launches.
